Associated Papers
Association between gene polymorphisms in the cyclophosphamide metabolism pathway with complications after haploidentical hematopoietic stem cell transplantation.
Muñiz P et al.
Frontiers in Immunology, 2022
36211438 (PubMed )
Supplement: Table_1.xlsx › Hoja1
Genome sequencing analysis of blood cells identifies germline haplotypes strongly associated with drug resistance in osteosarcoma patients.
Bhuvaneshwar K et al.
Bmc Cancer, 2019
30991985 (PubMed )
Supplement: 12885_2019_5474_MOESM4_ESM.xlsx › 2016NovDec12_2016Dec12_85_15_GL
Distribution of polymorphic variants of CYP2A6 and their involvement in nicotine addiction.
López-Flores LA et al.
Excli Journal, 2017
Novel CYP2A6 variants identified in African Americans are associated with slow nicotine metabolism in vitro and in vivo.
Piliguian M et al.
Pharmacogenetics and Genomics, 2014
Potentially functional SNPs (pfSNPs) as novel genomic predictors of 5-FU response in metastatic colorectal cancer patients.
Wang J et al.
Plos One, 2014
25372392 (PubMed )
Supplement: pone.0111694.s006.pdf
Efavirenz intoxication due to a new CYP2B6 constellation.
Anagnostopoulos A et al.
Antiviral Therapy, 2013
A novel duplication type of CYP2A6 gene in African-American population.
Fukami T et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals, 2007
Three haplotypes associated with CYP2A6 phenotypes in Caucasians.
Haberl M et al.
Pharmacogenetics and Genomics, 2005
Novel mutations of the CYP2A6 gene in a Thai population with lowered capacity of coumarin 7-hydroxylation.
Kiyotani K et al.
Drug Metabolism and Pharmacokinetics, 2002
Select a paper to view details